Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genital Human Papilloma Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00120848
What this trial is testing

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 776
Early research (Phase 1)Study completedNCT02405520
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 145
Testing effectiveness (Phase 2)UnknownNCT02640820
What this trial is testing

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

Who this might be right for
Common WartsHPV (Human Papillomavirus)Periungual Warts+1 more
RXi Pharmaceuticals, Corp. 83
Not applicableNot Yet RecruitingNCT07667127
What this trial is testing

Comparing Digital and Collaborative Gamified Reinforcement Strategies for HPV Literacy and Retention Among Nursing Students

Who this might be right for
Health LiteracyHuman Papillomavirus (HPV) InfectionNursing Education
Aydin Adnan Menderes University 64
Large-scale testing (Phase 3)Study completedNCT00578227
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 814
Not applicableNot Yet RecruitingNCT07697196
What this trial is testing

Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA Integration

Who this might be right for
HPV InfectionHPV IntegrationHPV Disease+3 more
IRCCS San Raffaele 42
Testing effectiveness (Phase 2)Study completedNCT00689741
What this trial is testing

Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,113
Not applicableStudy completedNCT01101542
What this trial is testing

Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 3,091
Not applicableLooking for participantsNCT06598475
What this trial is testing

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Who this might be right for
Human Papillomavirus Infection
The University of Texas Health Science Center, Houston 225
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Testing effectiveness (Phase 2)Study completedNCT00693966
What this trial is testing

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 210
Testing effectiveness (Phase 2)Looking for participantsNCT06756269
What this trial is testing

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Who this might be right for
HPV InfectionHPV-Related CarcinomaHPV-Related Intraepithelial Neoplasia+1 more
Shanghai Bovax Biotechnology Co., Ltd. 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06705322
What this trial is testing

Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.

Who this might be right for
Human Papillomavirus (HPV) InfectionCervical Cancer
Fudan University 79
Not applicableStudy completedNCT03000933
What this trial is testing

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

Who this might be right for
Human PapillomavirusHuman Papillomavirus Infection
The Alfred 200
Not applicableActive Not RecruitingNCT04574635
What this trial is testing

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

Who this might be right for
Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more
Mayo Clinic 18
Large-scale testing (Phase 3)Study completedNCT00543543
What this trial is testing

Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 14,840
Testing effectiveness (Phase 2)WithdrawnNCT00365443
What this trial is testing

Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)

Who this might be right for
Cervical CancerCondylomata Acuminata
Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)UnknownNCT01021904
What this trial is testing

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

Who this might be right for
HPV InfectionsPrecancerous Disease of the CervixCervical Cancer+1 more
Chinese Academy of Medical Sciences 6,200
Not applicableStudy completedNCT05109533
What this trial is testing

Probiotics Role in HPV Cervico-vaginal Infection Clearance

Who this might be right for
Vaginal InfectionHPV Infection
Azienda Ospedaliero, Universitaria Pisana 483
Large-scale testing (Phase 3)Study completedNCT02114385
What this trial is testing

Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)

Who this might be right for
Papilloma Viral Infection
Merck Sharp & Dohme LLC 500
Next Page